188 related articles for article (PubMed ID: 20098451)
1. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
Ayala-Ramirez M; Callender GG; Kupferman ME; Rich TA; Chuang HH; Trent J; Perrier ND; Goodarzi M; Jimenez C
Nat Rev Endocrinol; 2010 Feb; 6(2):110-5. PubMed ID: 20098451
[TBL] [Abstract][Full Text] [Related]
2. Carney Stratakis syndrome in a patient with SDHD mutation.
Tenorio Jiménez C; Izatt L; Chang F; Moonim MT; Carroll PV; McGowan BM
Endocr Pathol; 2012 Sep; 23(3):181-6. PubMed ID: 22638655
[No Abstract] [Full Text] [Related]
3. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
4. Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.
Pitsava G; Settas N; Faucz FR; Stratakis CA
Front Endocrinol (Lausanne); 2021; 12():680609. PubMed ID: 34012423
[TBL] [Abstract][Full Text] [Related]
5. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
[TBL] [Abstract][Full Text] [Related]
6. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
[TBL] [Abstract][Full Text] [Related]
7. Metastatic pheochromocytoma and paraganglioma.
Angelousi A; Kassi E; Zografos G; Kaltsas G
Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
[TBL] [Abstract][Full Text] [Related]
8. Multiple pheochromocytomas and paragangliomas in a young patient carrying a SDHD gene mutation.
Novosel A; Heger A; Lohse P; Schmidt H
Eur J Pediatr; 2004 Dec; 163(12):701-3. PubMed ID: 15365827
[TBL] [Abstract][Full Text] [Related]
9. The approach to the patient with paraganglioma.
Neumann HP; Eng C
J Clin Endocrinol Metab; 2009 Aug; 94(8):2677-83. PubMed ID: 19657044
[TBL] [Abstract][Full Text] [Related]
10. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract][Full Text] [Related]
11. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma.
Thompson MJ; Parameswaran V; Burgess JR
Ann Clin Biochem; 2019 Jan; 56(1):163-169. PubMed ID: 30373390
[TBL] [Abstract][Full Text] [Related]
13. Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations.
Choi Jdo W; Tucker KM; Lee TT; Chong GC
Head Neck; 2014 Oct; 36(10):E99-E102. PubMed ID: 24375508
[TBL] [Abstract][Full Text] [Related]
14. Carney triad versus Carney Stratakis syndrome: two cases which illustrate the difficulty in distinguishing between these conditions in individual patients.
Alrashdi I; Bano G; Maher ER; Hodgson SV
Fam Cancer; 2010 Sep; 9(3):443-7. PubMed ID: 20119652
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the diagnosis of pheochromocytoma and paraganglioma syndrome.
Zdrojowy-Wełna A; Bednarek-Tupikowska G
Neuro Endocrinol Lett; 2014; 35(5):355-8. PubMed ID: 25275255
[TBL] [Abstract][Full Text] [Related]
16. PGL4 syndrome in a patient with synchronous paraganglioma-pheochromocytoma.
Roque JJN; Martins C; Bugalho MJGM
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351744
[TBL] [Abstract][Full Text] [Related]
17. Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.
Jasperson KW; Kohlmann W; Gammon A; Slack H; Buchmann L; Hunt J; Kirchhoff AC; Baskin H; Shaaban A; Schiffman JD
Fam Cancer; 2014 Jun; 13(2):257-65. PubMed ID: 23934599
[TBL] [Abstract][Full Text] [Related]
18. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?
Lee SC; Chionh SB; Chong SM; Taschner PE
Laryngoscope; 2003 Jun; 113(6):1055-8. PubMed ID: 12782822
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
20. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
Barletta JA; Hornick JL
Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
